{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:29:37Z","timestamp":1787318977679,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022799","name":"Werner and Hedy Berger-Janser Foundation for Research into Cancer Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004152","name":"Spine Education and Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007352","name":"Staatssekretariat f\u00fcr Bildung, Forschung und Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.radonc.2025.111040","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:52:32Z","timestamp":1752580352000},"page":"111040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Long-term urinary continence and influencing factors after salvage radiotherapy: results of the SAKK 09\/10 dose escalation trial"],"prefix":"10.1016","volume":"211","author":[{"given":"Christina","family":"Schr\u00f6der","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-7735","authenticated-orcid":false,"given":"Daniel R.","family":"Zwahlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6108-4832","authenticated-orcid":false,"given":"S\u00e4mi","family":"Sch\u00e4r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9991-6152","authenticated-orcid":false,"given":"Tobias","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0498-2692","authenticated-orcid":false,"given":"Guido","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt-Christian","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Martin","family":"Putora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5619-747X","authenticated-orcid":false,"given":"Alexandros","family":"Papachristofilou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Sch\u00e4r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-6559","authenticated-orcid":false,"given":"Stefanie","family":"Hayoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Sumila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Zaugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-9071","authenticated-orcid":false,"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2203-4848","authenticated-orcid":false,"given":"Piet","family":"Ost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2654-1281","authenticated-orcid":false,"given":"Davide Giovanni","family":"Bosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7236-7269","authenticated-orcid":false,"given":"Silvia","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaouthar","family":"Khanfir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9508-0546","authenticated-orcid":false,"given":"Oliver","family":"Riesterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Thalmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Aebersold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirus","family":"Ghadjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111040_b0005","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year Outcomes after monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.radonc.2025.111040_b0010","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(05)67101-2","article-title":"Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)","volume":"366","author":"Bolla","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111040_b0015","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111040_b0020","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/jama.296.19.2329","article-title":"Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial","volume":"296","author":"Thompson","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.radonc.2025.111040_b0025","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial","volume":"181","author":"Thompson","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","article-title":"Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02\/AUO AP 09\/95 trial","volume":"66","author":"Wiegel","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0035","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","article-title":"Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02\/AUO AP 09\/95","volume":"27","author":"Wiegel","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0040","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0045","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111040_b0050","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0055","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(20)31952-8","article-title":"Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data","volume":"396","author":"Vale","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111040_b0060","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.eururo.2013.11.045","article-title":"Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy","volume":"66","author":"Briganti","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0065","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.eururo.2011.04.021","article-title":"High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results","volume":"60","author":"Ost","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0070","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.eururo.2021.05.033","article-title":"Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer after Prostatectomy: the SAKK 09\/10 Randomized phase 3 Trial","volume":"80","author":"Ghadjar","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0075","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.eururo.2016.11.015","article-title":"Functional Outcomes and Quality of Life after Radical Prostatectomy only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy","volume":"71","author":"Adam","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00345-024-04824-6","article-title":"Robot-assisted vs open retropubic radical prostatectomy: a propensity score-matched comparative analysis based on 15 years and 18,805 patients","volume":"42","author":"Ambrosini","year":"2024","journal-title":"World J. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0085","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3389\/fonc.2020.01207","article-title":"Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence after Post-prostatectomy Radiotherapy: evidence of Dose and Fractionation Effects","volume":"10","author":"Bresolin","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2012.05.045","article-title":"Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy","volume":"62","author":"Ficarra","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133243","article-title":"Predictors of Patient-Reported Incontinence at Adjuvant\/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy","volume":"13","author":"Munoz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.111040_b0100","first-page":"26","article-title":"Salvage radiotherapy after radical prostatectomy: long-term results of urinary incontinence, toxicity and treatment outcomes","volume":"11","author":"van Dessel","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111040_b0105","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.juro.2016.09.079","article-title":"Early Postoperative Radiotherapy is Associated with worse Functional Outcomes in patients with Prostate Cancer","volume":"197","author":"Zaffuto","year":"2017","journal-title":"J. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0110","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-Reported Outcomes after monitoring, Surgery, or Radiotherapy for Prostate Cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.radonc.2025.111040_b0115","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.radonc.2025.111040_b0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2340\/sju.v58.7318","article-title":"Salvage radiotherapy after radical prostatectomy: functional outcomes in the LAPPRO trial after 8-year follow-up","volume":"58","author":"Carlsson","year":"2023","journal-title":"Scand J Urol"},{"key":"10.1016\/j.radonc.2025.111040_b0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.euros.2023.04.005","article-title":"The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer patients Treated with Surgery and Salvage Radiotherapy","volume":"53","author":"Hjelle","year":"2023","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.radonc.2025.111040_b0130","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.annonc.2024.03.010","article-title":"Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)","volume":"35","author":"Parker","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0135","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2217\/fon-2021-1420","article-title":"Self-reported functional assessment after treatment for prostate cancer: 5-year results of the prospective cohort VICAN","volume":"18","author":"Pignot","year":"2022","journal-title":"Future Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/0284186X.2023.2224051","article-title":"Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy","volume":"62","author":"Saelen","year":"2023","journal-title":"Acta Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0145","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1200\/JCO.2015.63.3529","article-title":"Acute Toxicity and Quality of Life after Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer after Prostatectomy: first results of the Randomized Trial SAKK 09\/10","volume":"33","author":"Ghadjar","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2017.10.025","article-title":"Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: results of the randomized trial SAKK 09\/10","volume":"126","author":"Ghadjar","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2007.07.017","article-title":"Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group","volume":"84","author":"Poortmans","year":"2007","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijrobp.2021.12.174","article-title":"Adherence to Contouring and Treatment Planning Requirements within a Multicentric Trial: results of the Quality Assurance of the SAKK 09\/10 trial","volume":"113","author":"Beck","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111040_b0165","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.radonc.2025.111040_b0170","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.ejca.2008.07.030","article-title":"An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer","volume":"44","author":"van Andel","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.radonc.2025.111040_b0175","first-page":"65","article-title":"Swiss Group for Clinical Cancer R. patients' estimation of overall treatment burden: why not ask the obvious?","volume":"20","author":"Bernhard","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0180","series-title":"on behalf of the EORTC Quality of Life Group. the EORTC QLQ-C30 Scoring Manual (3rd Edition)","author":"Fayers","year":"2001"},{"key":"10.1016\/j.radonc.2025.111040_b0185","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2013.01.027","article-title":"Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy","volume":"65","author":"Suardi","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0190","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijrobp.2019.09.047","article-title":"Toxicity and Biochemical Outcomes of Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: results of a Randomized phase III Trial","volume":"106","author":"Qi","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111040_b0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00066-018-1359-2","article-title":"Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy","volume":"195","author":"Vogel","year":"2019","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.radonc.2025.111040_b0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijrobp.2019.06.004","article-title":"Quality of Life changes >10 Years after Postoperative Radiation Therapy after Radical Prostatectomy for Prostate Cancer","volume":"105","author":"Leufgens","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111040_b0205","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.juro.2017.02.3344","article-title":"The risks and Benefits of Cavernous Neurovascular Bundle Sparing during Radical Prostatectomy: a Systematic Review and Meta-Analysis","volume":"198","author":"Nguyen","year":"2017","journal-title":"J. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0210","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.eururo.2014.10.020","article-title":"Preservation of the neurovascular bundles is associated with improved time to continence after radical prostatectomy but not long-term continence rates: results of a systematic review and meta-analysis","volume":"68","author":"Reeves","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.23736\/S2724-6051.20.04178-8","article-title":"A systematic review of nerve-sparing surgery for high-risk prostate cancer","volume":"73","author":"Morozov","year":"2021","journal-title":"Minerva Urol Nephrol"},{"key":"10.1016\/j.radonc.2025.111040_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071644","article-title":"Prediction of Incontinence after Robot-Assisted Radical Prostatectomy: Development and Validation of a 24-month Incontinence Nomogram","volume":"14","author":"Pinkhasov","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.111040_b0225","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11701-020-01145-9","article-title":"Patient reported outcome measures concerning urinary incontinence after robot assisted radical prostatectomy: development and validation of an online prediction model using clinical parameters, lower urinary tract symptoms and surgical experience","volume":"15","author":"Collette","year":"2021","journal-title":"J. Robot. Surg."},{"key":"10.1016\/j.radonc.2025.111040_b0230","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.eururo.2016.03.010","article-title":"The effect of Salvage Radiotherapy and its timing on the Health-related Quality of Life of Prostate Cancer patients","volume":"70","author":"van Stam","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.111040_b0235","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111040_b0240","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0245","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer","volume":"35","author":"Catton","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0250","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.20.03282","article-title":"Prostate-only Versus Whole-Pelvic Radiation Therapy in High-Risk and very High-Risk Prostate Cancer (POP-RT): Outcomes from phase III Randomized Controlled Trial","volume":"39","author":"Murthy","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0255","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030696","article-title":"Stereotactic Radiotherapy after Radical Prostatectomy in patients with Prostate Cancer in the Adjuvant or Salvage setting: a Systematic Review","volume":"14","author":"Schroder","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.111040_b0265","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaoncol.2023.7291","article-title":"Noninferiority of Hypofractionated vs conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: the NRG-GU003 phase 3 Randomized Clinical Trial","volume":"10","author":"Buyyounouski","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.radonc.2025.111040_b0270","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijrobp.2023.04.032","article-title":"Salvage Radiation Therapy after Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial","volume":"117","author":"Petersen","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.111040_b0275","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11547-022-01479-4","article-title":"Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy","volume":"127","author":"Nicosia","year":"2022","journal-title":"Radiol. Med."}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402504544X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402504544X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:41:51Z","timestamp":1762256511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402504544X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":55,"alternative-id":["S016781402504544X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111040","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term urinary continence and influencing factors after salvage radiotherapy: results of the SAKK 09\/10 dose escalation trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111040"}}